title: [Magnesium sulfate in obstetrics: current data].
abstract: OBJECTIVE
  To review the available evidence regarding history, pharmacology, physiology, maternal/fetal side effects, and efficacy of magnesium sulfate in pregnant women.
  
  
  METHODS
  The literature in Medline was searched from 1966 through April 2003 using the terms "magnesium sulfate," "tocolytic," "preeclampsia," "eclampsia," and "pregnancy." Reviews of bibliographies of retrieved articles provided additional references.
  
  
  RESULTS
  Magnesium sulfate (MgSO4) has long been used for prophylaxis of preterm delivery (tocolytic affect) and eclampsia prophylaxis (neuroprotective effect). Randomized controlled trials and systematic reviews have demonstrated the efficacy of magnesium sulfate in preventing eclampsia in patients with preeclampsia or in patients with eclampsia. Whether magnesium sulfate should be administered to patients with severe preeclampsia or to mild preeclampsia is discussed in the manuscript. Inversely, it appears that magnesium sulfate is ineffective in delaying birth or preventing preterm birth when it is used as a tocolytic. Furthermore, there is evidence that high cumulative doses of magnesium sulfate may be associated with increased infant mortality.
  
  
  CONCLUSIONS
  The evidence to date confirms the efficacy of magnesium sulfate therapy for women with eclampsia and preeclampsia. However, magnesium sulfate should not be used in order to treat preterm labor.
authors.affiliation: Maternité Port Royal, Hôpital Cochin, Université René Descartes, Paris V, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Azria
authors.forename: V
authors.initials: V
authors.lastname: Tsatsaris
authors.forename: F
authors.initials: F
authors.lastname: Goffinet
authors.forename: G
authors.initials: G
authors.lastname: Kayem
authors.forename: A
authors.initials: A
authors.lastname: Mignon
authors.forename: D
authors.initials: D
authors.lastname: Cabrol
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004461:Eclampsia / Q000188:drug therapy / Q000517:prevention & control; D005260:Female; D006801:Humans; D008278:Magnesium Sulfate / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D012449:Safety; D015149:Tocolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000927:Anticonvulsants; D015149:Tocolytic Agents; D008278:Magnesium Sulfate